Jason Scott Slakter, Chief Executive Officer at Ohr Pharmaceutical Inc (OHRP), bought 3,682 shares at $3.14 ($11K) on 2016-05-25, disclosed to the SEC on 2016-05-26.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.09 | 500 | $2K | 13.5% |
| 2 | $3.10 | 2,000 | $6K | 54.2% |
| 3 | $3.11 | 100 | $311 | 2.7% |
| 4 | $3.13 | 682 | $2K | 18.6% |
| 5 | $3.14 | 100 | $314 | 2.7% |
| 6 | $3.14 | 300 |
| $942 |
| 8.2% |
| Total | $3.11 avg | 3,682 | $11K | 100% |
| Filing → |
| OHRP | BUY | 2016-05-25 | $89K | — | Filing → |
| OHRP | BUY | 2016-04-12 | $21K | — | Filing → |
| OHRP | BUY | 2016-03-09 | $23K | — | Filing → |